US 11,952,634

Application 17/523,235 · Granted Apr 9, 2024

Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

Estimated expiration

December 8, 2035

9y 19d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Dec 8, 2015
+ 20 years
Dec 8, 2035
PTA +123d
Apr 9, 2036
TD cap (US 11,186,876)
Dec 8, 2035
Final
Dec 8, 2035

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
November 10, 2021
Earliest effective filing
December 8, 2015
Issue date
April 9, 2024
PTA
+123 days
Base expiry (before PTA)
December 8, 2035

December 8, 2015 + 20 years = December 8, 2035 + 123 PTA days = April 9, 2036

  • Continuation of application 16/215,340, filed Dec 10, 2018, issued as US 11,186,876
  • Continuation of application 14/962,864, filed Dec 8, 2015, issued as US 10,196,693
  • Continuation of application 14/962,864, filed Dec 8, 2015, issued as US 10,196,693
  • PRO62/091,195 — Provisional — not used for base term
  • PRO62/142,504 — Provisional — not used for base term
  • PRO62/167,110 — Provisional — not used for base term
  • PRO62/091,195 — Provisional — not used for base term
  • PRO62/142,504 — Provisional — not used for base term
  • PRO62/167,110 — Provisional — not used for base term
  • PRO62/091,195 — Provisional — not used for base term
  • PRO62/142,504 — Provisional — not used for base term
  • PRO62/167,110 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to December 8, 2035 (earliest expiring referenced patent: US 11,186,876)

  • US 9,636,000

    Could not resolve calculation details

  • US 11,186,876· Application 16/215,340Capping patent

    Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

    Filing date
    Dec 10, 2018
    Earliest effective filing
    Dec 8, 2015
    Issue date
    Nov 30, 2021
    PTA
    0 days
    Calculated expiration
    Dec 8, 2035

    Continuation of 14/962,864, filed Dec 8, 2015, issued as US 10,196,693

    Dec 8, 2015 + 20y = Dec 8, 2035

  • US 10,196,693· Application 14/962,864

    Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

    Filing date
    Dec 8, 2015
    Earliest effective filing
    Dec 8, 2015
    Issue date
    Feb 5, 2019
    PTA
    0 days
    Calculated expiration
    Dec 8, 2035

    Dec 8, 2015 + 20y = Dec 8, 2035

  • US 11,952,634· Application 17/523,235(from application 17/523,235)

    Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

    Filing date
    Nov 10, 2021
    Earliest effective filing
    Dec 8, 2015
    Issue date
    Apr 9, 2024
    PTA
    +123 days
    Calculated expiration
    Apr 9, 2036

    Continuation of 16/215,340, filed Dec 10, 2018, issued as US 11,186,876

    Continuation of 14/962,864, filed Dec 8, 2015, issued as US 10,196,693

    Continuation of 14/962,864, filed Dec 8, 2015, issued as US 10,196,693

    Dec 8, 2015 + 20y + 123d PTA = Apr 9, 2036

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/523,235 · US 11,952,634

PatentReply compiles the prosecution history behind US 11,952,634: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11952634

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.